An unexpected cause for aplastic anaemia in an elderly woman

Phua, C. K.; Marimuthu, K.; Teo, H. Y.; Ong, K. H.; Leo, Y. S.
February 2013
International Journal of STD & AIDS;Feb2013, Vol. 24 Issue 2, p154
Academic Journal
Case Study
Aplastic anaemia is a rare clinical syndrome associated with diminished or absent precursors in the bone marrow. Acquired aplastic anaemia secondary to human immunodeficiency virus (HIV) is very rare. We present a 71-year-old woman with severe aplastic anaemia secondary to HIV infection, which was after extensive exclusion of other causes. She achieved undetectable viral load after 5 months of combination antiretroviral therapy but remains profoundly pancytopenic, complicated by recurrent infectious and bleeding complications. HIV infection should be considered in patients with pancytopenia.


Related Articles

  • Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. Takahata, M; Hashino, S; Izumiyama, K; Chiba, K; Suzuki, S; Asaka, M // Bone Marrow Transplantation;10/1/2001, Vol. 28 Issue 7, p713 

    A 21-year-old woman with severe aplastic anemia received an allogeneic bone marrow transplant (allo-BMT) from an HLA-matched and ABO-matched sibling donor after conditioning with cyclophosphamide, rabbit ATG (Lymphoglobuline; Aventis-Pharma), and total lymphoid irradiation. She had a long...

  • Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Ghavamzadeh, A; Alimoghadam, K; Nasseri, P; Jahani, M; Khodabandeh, A; Ghahremani, G // Bone Marrow Transplantation;2/1/99, Vol. 23 Issue 3, p299 

    Dyskeratosis congenita is recognized by its dermal lesions and constitutional aplastic anemia in some cases. We report successful allogeneic bone marrow transplantation in two siblings with this disease from their sister, and their long term follow-up. We used reduced doses of cyclophosphamide...

  • Hepatic injury localized to the field of total lymphoid irradiation. Murata, M; Muramoto, H; Kojima, Y; Nishida, T; Haneda, M; Kanie, T; Taji, H; Hamaguchi, M; Minami, S; Imaeda, T; Kodera, Y // Bone Marrow Transplantation;11/15/97, Vol. 20 Issue 10, p897 

    A 37-year-old woman with severe aplastic anemia underwent allogeneic bone marrow transplantation following cyclophosphamide (CY) and total lymphoid irradiation (TLI). On day +30, a CT scan was carried out because of a mild elevation in liver enzymes, and it revealed a low density area with a...

  • Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia. Dufour, C; Dallorso, S; Casarino, L; Corcione, A; Pistoia, V; Bacigalupo, A; Morreale, G; Dini, G // Bone Marrow Transplantation;4/1/99, Vol. 23 Issue 7, p743 

    A 14-year-old patient with acquired very severe aplastic anemia (VSAA) underwent bone marrow transplantation (BMT) from his HLA-identical brother. Preparative therapy was cyclophosphamide (CY) 200 mg/kg over 4 days. GVHD prophylaxis was with cyclosporin A (CsA) for a year. After an 8 year...

  • Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors. Suzuki, H; Asano, H; Ohashi, H; Kinoshita, T; Murate, T; Saito, H; Hotta, T // Leukemia (08876924);Jan99, Vol. 13 Issue 1, p130 

    X chromosome inactivation and polymorphism of the human androgen receptor (HUMARA) gene has been applied for analyzing the clonality of blood cells. In the present study, the clonal relationship was investigated between peripheral blood polymorphonuclear cells (PMNCs) and marrow progenitor cells...

  • Bone marrow donor needed for Brooklyn 5-year-old.  // New York Amsterdam News;08/19/99, Vol. 90 Issue 34, p14 

    Reports that New York, New York resident Shanice Murphy is in need of a bone marrow donor. Murphy as a five-year-old child suffering from aplastic anemia; Patient's need for a bone marrow transplant; Brookdale University Hospital and Medical Center's announcement of the donor search.

  • Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia. Brodsky, Robert A.; Sensenbrenner; Smith, B. Douglas; Dorr, Donna; Seaman, Phillip J.; Lee, Shing M.; Karp, Judith E.; Brodsky, Isadore; Jones, Richard J. // Annals of Internal Medicine;10/2/2001, Vol. 135 Issue 7, p477 

    Background: Severe aplastic anemia is a life-threatening bone marrow failure disorder. High-dose cyclophosphamide therapy followed by allogeneic bone marrow transplantation cures the disease. However, it requires a suitable donor and carries the risk for graft-versus-host disease. A small pilot...

  • Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma. Moritake, H; Ikuno, Y; Tasaka, H; Koga, H; Miyazaki, S; Okamura, J // Bone Marrow Transplantation;4/1/98, Vol. 21 Issue 7, p725 

    A 10-year-old boy with metastatic rhabdomyosarcoma had an HLA-identical sibling and received an allogeneic BMT. Recurrence was detected in the BM as the only site of treatment failure 12 months after BMT. Donor leukocyte infusion (DLI) was chosen as salvage therapy. Although sufficient cells (a...

  • Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Abdelkefi, Abderrahman; Othman, Tarek Ben; Ladeb, Saloua; Torjman, Lamia; Hsairi, Mohamed; Abdeladhim, Abdeladhim Ben // Hematology Journal;2003, Vol. 4 Issue 3, p208 

    Between 1998 and 2001, 31 (24 male, 7 female) patients with severe aplastic anemia (SAA) and a median age of 19 years (range, 4-39 years) received an allogeneic bone marrow transplantation. Marrow donors were genotypically HLA-identical siblings in 30 cases and a monozygous twin in one case. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics